Subscribe to our mailing list to receive the latest shareholder communication
A Series A opportunity to invest in New Zealand's most exciting MedTech Start-Up
The Insides Company is the developer and manufacturer of therapeutic chyme reinfusion solutions for patients recovering from complex intestinal diseases, including colorectal cancer, inflammatory bowel disease and enterocutaneous fistula.
The Insides Company is now raising a $5 million round to achieve FDA clearance, reimbursement and early sales in key European Countries.
Click here to read more or contact The Insides Company for Investment-related enquiries and opportunities.